key: cord-0297938-wpe8vkqa authors: Brothers, T. D.; Leaman, M.; Bonn, M.; Lewer, D.; Atkinson, J.; Fraser, J.; Gillis, A.; Gniewek, M.; Hawker, L.; Hayman, H.; Jorna, P.; Martell, D.; O'Donnell, T.; Rivers-Bowerman, H.; Genge, L. title: Evaluation of an emergency safe supply drug and managed alcohol program in COVID-19 isolation hotel shelters for people experiencing homelessness date: 2022-01-17 journal: nan DOI: 10.1101/2022.01.14.22269074 sha: efb936528cb7e4e6f67fbd641d07ce900d4648e1 doc_id: 297938 cord_uid: wpe8vkqa Background: During a COVID-19 outbreak in the congregate shelter system in Halifax, Nova Scotia, Canada, a multidisciplinary health care team provided an emergency safe supply of pharmaceutical-grade medications and beverage-grade alcohol to facilitate isolation in COVID-19 hotel shelters for residents who are dependent on these substances. We aimed to evaluate (a) substances and dosages provided, and (b) effectiveness and safety of the program. Methods: We retrospectively reviewed medical records of all COVID-19 isolation hotel shelter residents during May 2021. We extracted data on medication and alcohol dosages provided each day. The primary outcome was residents prematurely leaving isolation against public health orders. Adverse events included (a) overdose; (b) intoxication; and (c) diversion, selling, or sharing of medications or alcohol. Results: Over 25 days, 77 isolation hotel residents were assessed (mean age 42 +/- 14 years; 24% women). Sixty-two (81%) residents were provided medications, alcohol, or cigarettes. Seventeen residents (22%) received opioid agonist treatment medications (methadone, buprenorphine, or slow-release oral morphine) and 27 (35%) received hydromorphone tablets. Thirty-one (40%) residents received stimulant tablets with methylphenidate (27; 35%), dextroamphetamine (8; 10%), or lisdexamfetamine (2; 3%). Six residents (8%) received benzodiazepines. Forty-two (55%) residents received alcohol, including 41 (53%) with strong beer, three (3%) with wine, and one (1%) with hard liquor. Over 14 days in isolation, mean daily dosages increased of hydromorphone (45 +/- 32 to 57 +/- 42mg), methylphenidate (51 +/- 28 to 77 +/- 37mg), dextroamphetamine (33 +/- 16 to 46 +/- 13mg), and alcohol (12.3 +/- 7.6 to 13.0 +/- 6.9 standard drinks). Six residents (8%) left isolation prematurely, but four of those residents returned. Over 1,059 person-days in isolation, there were zero overdoses. Documented concerns regarding intoxication occurred six times (0.005 events/person-day) and medication diversion or sharing three times (0.003 events/person-day). Conclusions: An emergency safe supply and managed alcohol program, paired with housing, was associated with low rates of adverse events and high rates of successful completion of the 14-day isolation period in COVID-19 isolation hotel shelters. This supports the effectiveness and safety of emergency safe supply prescribing and managed alcohol in this setting. The COVID-19 pandemic and associated public health restrictions have had a disproportionate impact on 60 people who use drugs and/or alcohol (1) (2) (3) . Disruptions to drug supply routes have led to an increasingly 61 toxic and unpredictable drug supply, while physical distancing requirements cause more people to use 62 drugs alone (where they cannot be resuscitated if they overdose) and have reduced capacity and 63 operating hours at harm reduction and addiction treatment programs (4-6). People who are dependent 64 on substances may be unable to follow public health directives to isolate if they have been exposed to 65 COVID-19, due to withdrawal symptoms or compulsive use (1) . For people who use drugs and/or alcohol 66 and are also experiencing homelessness, staying in congregate shelters increases risks of COVID-19 67 infection; people in this situation would be unable to isolate unless given a private place to stay (7,8). To facilitate physical distancing and decrease risks of COVID-19 infection, withdrawal, and overdose, 70 Canadian clinicians developed rapid guidelines to provide a regular, safe supply of pharmaceutical-grade 71 drugs and of beverage-grade alcohol to people who are dependent on these substances (9-12). The 72 rationale for providing an alternative "safe supply" of substances to remove harms caused by reliance 73 on the criminalized, unregulated, and poisonous drug market was first advanced by the Canadian 74 Association of People who Used Drugs (CAPUD) (1, 13, 14) and developed clinically by Sereda and 75 colleagues(15) and by Tyndall and colleagues(16) , before the COVID-19 pandemic. Provisional 76 prescribing of safe supply medications and managed alcohol to facilitate COVID-19 related physical 77 distancing or isolation has also been termed "risk mitigation" or "pandemic prescribing" (1, 9, (17) (18) (19) . . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted January 17, 2022. ; https://doi.org/10.1101/2022.01.14.22269074 doi: medRxiv preprint 107 Data were extracted from the shared electronic medical record, including progress notes, electronic 108 prescriptions, and messaging. Using structured chart review, each resident's information was extracted 109 in duplicate, once by a graduate student researcher (ML) and once by a clinician with experience 110 prescribing these medications (TDB, MG, or AG). Discrepancies were resolved by TDB. in Halifax; the organization has long-standing relationships with the city's shelters and many of the 118 residents. All residents being moved to isolation were referred to the harm reduction prescribing team 119 for assessment. Nurses, nurse practitioners, and physicians performed intake assessments on substance 120 use and health history; most assessments were done over the phone, but some were done in person. Prescribers had access to province-wide pharmacy information system to confirm patient reports of 122 prescribed medications, including opioid agonist treatment (OAT Prescribed medications could be taken orally, or crushed and injected or snorted; prescribers reviewed 145 with residents that oral tablets were not designed to be crushed and injected, and provided guidance on 146 safer use within a harm reduction framework. Resident preferences as to specific brands or formulations 147 (e.g. those that might be more soluble in water to facilitate safer injecting) were followed as closely as 148 possible. Liquid hydromorphone for injection use is not included in the BCCSU guidelines and was not 149 considered here; this oversight has been criticized by people who use drugs because of the relatively 150 increased harms associated with injecting oral tablets (27). Cannabis withdrawal is not mentioned in the 151 BCCSU guidelines and the prescribing team initially underappreciated the importance of cannabis 152 cravings and withdrawal symptoms (28), once other needs were met. While trying to facilitate funding 153 for cannabis deliveries to the hotels, prescribers began to offer nabilone as an agonist replacement 154 . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) The copyright holder for this preprint this version posted January 17, 2022. . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) The copyright holder for this preprint this version posted January 17, 2022. Over 25 days, 77 residents were admitted to COVID-19 isolation hotel shelters and referred to the 212 medical team (Table 2 ). In total, there were 1,059 person-days in isolation after medical assessment. Most participants were men, and average age differed by gender. Mean age for men was 46 ± 14 years, 214 and for women was 30 ± 10 years. After intake assessment, 15 residents (19%) were determined to have 215 no concerns about substance withdrawal or dependence while in isolation and were given no 216 medications, alcohol, or cigarettes. Sixty-two residents (81%) were provided medications, alcohol, or 217 cigarettes, summarized by day of isolation in Figure 1 . Cigarettes were the most commonly provided substance (64 residents; 83% of total sample), followed 220 by alcohol (42 residents; 55% of total sample), and hydromorphone tablets (27 residents; 35% of total 221 sample). Seventeen residents (22%) received any OAT, including eight who initiated OAT medications in 222 the isolation hotel shelters. All eight of these residents initiated SROM, and no residents initiated 223 methadone or buprenorphine-naloxone. Twelve residents received both OAT and hydromorphone 224 tablets on the same day (71% of residents receiving OAT); four of these residents were already on OAT 225 . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted January 17, 2022. ; before isolation. Two residents accepted offers of nicotine replacement therapy, including one resident 226 who also had cigarettes delivered. CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted January 17, 2022. ; https://doi.org/10.1101/2022.01.14.22269074 doi: medRxiv preprint Average daily alcohol dosages increased slightly over time from day one (mean 12.3 ± 7.6 standard 250 drinks; median 11.25 standard drinks; range 1.25 -33.75 standard drinks) to day 14 (mean 13.0 ± 6.9 CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted January 17, 2022. ; https://doi.org/10.1101/2022.01.14.22269074 doi: medRxiv preprint residents who also had documented intoxication. All three of these residents were provided multiple 273 substances, including opioids, stimulants, and alcohol. In Boston, OAT was offered but safe supply prescriptions and alcohol were not (49,52). Naloxone and 341 sterile syringes were distributed at discharge from the isolation shelters, but not provided to residents 342 . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted January 17, 2022. is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted January 17, 2022. ; https://doi.org/10.1101/2022.01.14.22269074 doi: medRxiv preprint isolation shelters against public advice. Nevertheless, the rate of premature discharge was lower here 367 than reported in San Francisco, and our findings here of relatively safety are reassuring. Second, as our 368 study relied on retrospective evaluation of medical records, we may be missing data on events 369 (including medication diversion, sharing, or selling) that were not disclosed to shelter staff. The program 370 described here did not have a systemic approach to surveillance or of gathering information on 371 diversion, sharing, or selling from shelter staff. Other study designs, including qualitative interviews, 372 could be used to get a better sense of the scale of medication diversion, sharing, and selling, that was 373 not reported back to the medical team. Third, as our study occurred in a city with relatively little 374 fentanyl and crystal methamphetamine use, the dosing ranges here may not be sufficient in populations 375 with higher drug tolerance and this may limit generalizability. We found that an emergency, provisional safe supply program providing pharmaceutical-grade 379 medications and beverage-grade alcohol in COVID-19 isolation hotel shelters was associated with low 380 rates of adverse events and of high rates of successful completion of the mandatory 14-day isolation 381 stay. This suggests this approach is safe and effective in this setting. . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted January 17, 2022. . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted January 17, 2022. CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted January 17, 2022. interim-clinical-guidance/ 472 . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted January 17, 2022. . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted January 17, 2022. is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted January 17, 2022. ; https://doi.org/10.1101/2022.01.14.22269074 doi: medRxiv preprint Table 1 . Summary of prescribing guidelines used in emergency safe supply drug and managed alcohol 677 program in COVID isolation hotels in Halifax. Summary of prescribing guidance • Offer OAT to all patients with opioid use disorder. • It is helpful to prescribe a long-acting opioid (e.g. slow-release oral morphine) in conjunction with a short-acting opioid for those not on OAT. • Oral hydromorphone 8mg tablets, 1-3 tablets every hour as needed. • Maximum daily dose of 14 tablets (112mg). • Methylphenidate SR 20-40mg tablets once daily and/or methylphenidate IR 10-20mg tablets twice daily. • Maximum daily dose of 100mg methylphenidate. • Dextroamphetamine SR 10-20mg tablets twice daily and/or dextroamphetamine IR 10-20mg tablets twice or thrice daily. • Maximum daily dose of 80-120mg dextroamphetamine. • If temporary maintenance is being prescribed, generally consider switching to a long-acting benzodiazepine (e.g. diazepam or clonazepam) and reduce dose by 50% to start and then titrate daily. • Convert patient-reported alcohol consumption into "Canadian Standard Drinks". • Most mouthwash estimated at 26% ABV, regular wine at 12% ABV, and fortified wine at 20%. • Prescribe managed alcohol dose in number of cans of strong beer (6% ABV; 1.25 standard drinks per can) or red wine (12% ABV; 5.2 standard drinks per 750mL bottle). Limited hard liquor (40% ABV; 0.69 standard drinks per ounce) was also available on a case-by-case basis. • Preference is to use beer, as it can be more easily spread throughout the day. • Offer nicotine replacement therapy (i.e., patch, gum, lozenge, inhaler). • Residents requiring tobacco would be delivered 1-2 packs of cigarettes daily by a local harm reduction organization outreach team. SR: sustained-release formulation. IR: immediate release formulation. ABV: Alcohol by volume. . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted January 17, 2022. ; https://doi.org/10.1101/2022.01.14.22269074 doi: medRxiv preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted January 17, 2022. ; https://doi.org/10.1101/2022.01.14.22269074 doi: medRxiv preprint . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) The copyright holder for this preprint this version posted January 17, 2022. ; Figure 1 . Number of COVID-19 isolation hotel shelter residents receiving each category of safe supply medications or managed alcohol during 14 days of isolation. Benzodiazepines include clonazepam and lorazepam. Stimulants include methylphenidate, dextroamphetamine, and lisdexamfetamine. Opioids include opioid agonist treatment medications (methadone, buprenorphine, or slow-release morphine) and hydromorphone. Alcohol includes strong beer, wine, or hard liquor. . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) The copyright holder for this preprint this version posted January 17, 2022. ; Addressing the 437 Syndemic of HIV, Hepatitis C, Overdose, and COVID-19 Among People Who Use Drugs: The 438 Potential Roles for Decriminalization and Safe Supply Measuring the Burden of Opioid-Related Mortality in 442 During the COVID-19 Pandemic Challenges in 446 maintaining treatment services for people who use drugs during the COVID-19 pandemic Innovative strategies to support physical 485 distancing among individuals with active addiction The Times They Are 491 a-Changin'": Addressing Common Misconceptions About the Role of Safe America's Overdose Crisis Safer Opioid Supply Programs 496 (SOS): A Harm Reduction Informed Guiding Document for Primary Care Teams Mu5ALM/edit?usp=embed_facebook An emergency response to the opioid overdose crisis in Canada: a regulated 501 opioid distribution program It's Helped Me a Lot Distribution Program in Vancouver, Canada Barriers and facilitators to a 583 novel low-barrier hydromorphone distribution program in Vancouver, Canada: a 584 qualitative study. Drug Alcohol Depend Managed Opioid Program (MOP) where supervised injectable 589 hydromorphone was paired with assisted housing Trajectories of Alcohol 593 Use and Related Harms for Managed Alcohol Program Participants over 12 Months 594 Compared with Local Controls: A Quasi-Experimental Study Does 598 managing the consumption of people with severe alcohol dependence reduce harm? A 599 comparison of participants in six Canadian managed alcohol programs with locally 600 recruited controls Perceived harms and harm 603 reduction strategies among people who drink non-beverage alcohol: Community-based 604 qualitative research in Vancouver Community 608 managed alcohol programs in Canada: Overview of key dimensions and implementation Heroin: it's just not an East Coast thing Concurrent 615 monitoring of opioid prescribing practices and opioid-related deaths: the context in Nova 616 Health Promot Chronic Dis Prev Can Investigating opioid 622 preference to inform safe supply services: A cross sectional study 626 Conceptualizing patient-centered care for substance use disorder treatment: findings from 627 a systematic scoping review Patient-centred care in opioid agonist treatment could improve 630 outcomes Caring for people who inject drugs when they are 633 admitted to hospital A 635 Descriptive Comparison of Substance Use Services in Recovery and Isolation Sites for 636 People Experiencing Homelessness During the COVID-19 Pandemic Finding stability amidst the COVID-640 19 pandemic: The impact of emergency temporary housing for people who use drugs The impact of an integrated 644 safer use space and safer supply program on non-fatal overdose among emergency shelter 645 residents during a COVID-19 Outbreak: A case study Integrating harm reduction and clinical care: Lessons 647 from Covid-19 respite and recuperation facilities Assessment of a 651 Hotel-Based COVID-19 Isolation and Quarantine Strategy for Persons Experiencing 652 Successful 655 implementation of managed alcohol programs in the San Francisco Bay Area during the 656 COVID-19 crisis Lisbon's COVID 19 659 response: harm reduction interventions for people who use alcohol and other drugs in 660 emergency shelters Harm reduction in an emergency 663 response to homelessness during South Africa's COVID-19 lockdown Gostin LO, Powers M. What Does Social Justice Require For The Public's Health? Public 670 Social Justice in Pandemic Preparedness. Am J 672 Public Health Figure 3 . COVID-19 isolation hotel shelter residents' daily dosage trajectories for safe supply stimulant medications. Individual daily medication dosages are plotted as percentages of the maximum daily dosages of each substance across the whole sample (i.e., methylphenidate 160mg; dextroamphetamine 80mg; lisdexamfetamine 60mg). Dark grey boxes represent days where substances could not be provided, either because resident was away from isolation or because of delayed medical assessment. ID: 66 ID: 67 ID: 68 ID: 69 ID: 74 ID: 75 1 3 5 7 9 11 13 1 3 5 7 9 11 13 1 3 5 7 9 11 13 1 3 5 7 9 11 13 1 3 5 7 9 11 13 1 3 5 7 9 11 13Days after entry to isolation Percent of maximum dose